Personal profile
Fingerprint
Dive into the research topics where Ki Young Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases
Yang, Y. S., Kim, M. J., Chaugule, S., Mayer, E., DeSouza, N., Ma, H., Xie, J., Lee, K. Y., Li, S., Gravallese, E., Gao, G. & Shim, J. H., 3 Dec 2025, In: Molecular Therapy. 33, 12, p. 6379-6397 19 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways
Shin, J. H., Kim, J. Y., Kim, M. J., Kang, Y., Lee, H. J., Choi, B., Lee, J. S., Kwon, D., Kim, S. H., Sung, Y., Kim, D. H., Shim, J. H., Chun, E. & Lee, K. Y., Nov 2025, In: Experimental and Molecular Medicine. 57, 11, p. 2559-2573 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
TXNIP Suppresses Lung Cancer Progression by Inhibiting TRAF6-Mediated NF-κB Activation and Autophagy
Kim, J. Y., Kim, M. J., Shin, J. H., Baik, K. H., Kang, Y., Sung, Y., Kim, S. H., Lee, H. J., Lee, C., Shim, J. H., Kim, D. H., Chun, E. & Lee, K. Y., Oct 2025, In: Immune Network. 25, 5, e33.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis
Shin, J. H., Kim, J. Y., Kim, S. H., Kang, Y., Lee, H. J., Kim, M. J., Choi, J., Jeong, S. K., Park, S. O., Cho, Y. B., Kim, K. K., Shim, J. H., Chun, E. & Lee, K. Y., Dec 2025, In: Cell Death and Disease. 16, 1, 894.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition
Shin, J. H., Kim, J. Y., Kim, M. J., Kang, Y., Choi, B., Kwon, D., Sung, Y., Kim, S. H., Lee, H. J., Lee, C., Kim, K. K., Shim, J. H., Kim, D. H., Chun, E. & Lee, K. Y., Dec 2025, In: Biomarker Research. 13, 1, 95.Research output: Contribution to journal › Letter › peer-review
Open Access5 Link opens in a new tab Scopus citations
Press/Media
-
Discovery of Novel Lung Cancer Biomarkers and Therapeutic Targets to Overcome Drug Resistance
21/11/25
1 Media contribution
Press/Media